QuantumPharm Inc (Ticker: 2228.HK) is a China-based AI drug research firm that provides drug discovery and intelligent automation solutions. Founded by MIT quantum physicists, the company collaborates with biotechnology and pharmaceutical companies as well as academic institutions. QuantumPharm will list on June 13, 2024, on the Stock Exchange of Hong Kong. The firm is selling a 5.5% stake, offering shares in the price range of HK$5.03 to HK$6.03. The total offer size is HK$1.13 billion (USD 114 million). Eight cornerstone investors have committed USD 43.6 million to the IPO. Major investors include Tencent, HongShan, SoftBank Group, Google, and OrbiMed.